Bone Biologics
Stock Forecast, Prediction & Price Target

Bone Biologics Financial Estimates

Bone Biologics Revenue Estimates

Bone Biologics EBITDA Estimates

Bone Biologics Earnings per Share Estimates

Passed Analyst forecast
Metric 12/31/2021 12/31/2022 12/31/2023 12/31/2025 12/31/2026
Revenue
 
% change YoY
$0
 
N/A
$0
 
0%
$0
 
0%
Avg: $0
Low: $0
High: $0
avg. 0%
Avg: $0
Low: $0
High: $0
avg. 0%
Net Income
 
% change YoY
$-1.61M
 
N/A
$695.93K
 
143.20%
$-8.94M
 
-1385.86%
Avg: $-3.88M
Low: $-1.27M
High: $-1.27M
avg. 56.57%
Avg: $-4.10M
Low: $-1.28M
High: $-1.28M
avg. -5.69%
EBITDA
 
% change YoY
$-1.10M
 
N/A
$-4.39M
 
-299.18%
$479.57K
 
110.90%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%
EPS
 
% change YoY
-$85.11
 
N/A
$14.62
 
117.17%
-$34.01
 
-332.62%
Avg: -$4.84
Low: -$4.84
High: -$4.84
avg. 85.76%
Avg: -$4.87
Low: -$4.87
High: -$4.87
avg. -0.61%
Operating Expenses
 
% change YoY
$1.10M
 
N/A
$3.66M
 
232.75%
$9.42M
 
157.24%
Avg: $0
Low: $0
High: $0
avg. -100%
Avg: $0
Low: $0
High: $0
avg. 0%

FAQ

What is Bone Biologics stock earnings growth forecast?

Wall Street analysts estimate the annual average earnings growth rate of 25.43% in 2025-2026.

We have gathered data from 1 analysts. Their low estimate is -1.27M, average is -3.88M and high is -1.27M.

What is Bone Biologics stock revenue growth forecast?

We have gathered data from 1 analysts. Their low revenue estimate is N/A, average is N/A and high is N/A.

What is Bone Biologics stock earnings per share growth forecast?

Wall Street analysts forecast annual average earnings growth of 42.57% in 2025-2026.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$4.84, average is -$4.84 and high is $-4.84.